The tweet was deleted by the author.
But we saved everything 🙂.
Monte Rosa Therapeutics has reaffirmed its dedication to fostering an inclusive work environment where employees do not have to choose between professional advancement and personal authenticity.
On the occasion of Pride Month, the company publicly celebrated the LGBTQ community and reiterated its commitment to ensuring that all staff feel valued, supported, and empowered. Monte Rosa Therapeutics positions itself as a champion for diversity and equality within the life sciences sector. Details about ongoing initiatives or updated workplace policies were not provided. Details are being clarified.
Monte Rosa Therapeutics has recently reported progress on its NEK7-targeted molecular glue MRT-8102 for cardiovascular inflammation treatment, according to a company update. The firm also provided a clinical pipeline overview and discussed its molecular glue degrader programs at the Jefferies Healthcare Conference earlier this year. The company continues to expand its business and research activities alongside workplace inclusion efforts.